Inspiremd Inc (NSPR) Stock Price, Quote & News

Company Profile

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid S...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 776 6804

Website: www.inspiremd.com

Address:

6303 Waterford District Drive, Suite 215, Miami, United States

LoyalShark Aug. 19 at 12:10 AM

$NSPR Incase you were wondering what to do.

0 · Reply

prismmarketview Aug. 18 at 2:52 PM

$NSPR — Q4 setting up as a catalyst quarter. Two FDA decisions on tap (CGuard Prime 80cm TCAR + original CAS system), plus full run-rate impact of a $9M cost-cutting plan (~20% headcount reduction) hitting books. Q2 rev was just $1.77M after the Prime 135cm recall hit gross margin, but intl revenue +21% YoY offers some offset. Redesigned 135cm heads back to FDA by year-end, US return targeted 1H27. https://prismmarketview.com/inspiremd-targets-q4-fda-decisions-while-cutting-9-million-in-annual-costs/

0 · Reply

LoyalShark Aug. 17 at 8:46 PM

$NSPR same problem webhave had for 7 years. Marvin Slosman

0 · Reply

RedDogSailor Aug. 17 at 7:15 PM

$NSPR Nice volume. No good reason to delist.

0 · Reply

woodstockery Aug. 17 at 6:31 PM

$NSPR ahem...

0 · Reply

TrkDvr Aug. 17 at 3:39 PM

$NSPR There reaches a point where everyone realizes what the actual situation is and has to consider the most practical solution. I think management is getting there but I'd like to suggest they consider delisting, not waste money trying to be a tradeable stock when nobody wants it and work through the challenges of becoming a commercially viable product. I own a bunch of stock which I'd like to sell but nobody wants it, so for myself - delisting is a next best step to be taken.

1 · Reply

Jonnie5 Aug. 17 at 2:10 PM

$NSPR when $5?

0 · Reply

HOBOWITHASHOTGUN Aug. 17 at 1:55 PM

$NSPR Volume...

1 · Reply

GiveHerTheDD Aug. 17 at 1:04 PM

$NSPR Earnings call additional info shared: - Recommercialization will likely occur in Q4, along with TCAR indication - All other timelines remain the same - 4 analysts covered the call (BTIG, Piper Sandler, Maxim, Lake Street) - Realized workforce reduction occurring now but related costs mostly being realized in Q4 Fingers crossed that this is the last pivot in timelines lol

2 · Reply

focafoca99 Aug. 17 at 11:16 AM

$NSPR delivered Q2 2026 results showing $1.8M revenue, a net loss of $14.3M and ongoing recall of its CGuard Prime 135 cm system. https://www.rapidticker.com/news/nspr-inspiremd-reports-second-quarter-2026-dd9622

0 · Reply

InspireMD Earnings Call Transcript: Q2 2026

Aug 17, 2026, 8:30 AM EDT - 2 days ago

InspireMD Quarterly report: Q2 2026

Aug 17, 2026, 8:30 AM EDT - 2 days ago

InspireMD Earnings release: Q2 2026

2026-08-17T11:30:25.000Z - 2 days ago

Market Cap	41.21M
Revenue (ttm)	8.98M
Net Income (ttm)	-48.79M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-543.32%
Debt to Equity Ratio	0.00

Volume	74,200
Avg Vol	103,570
Day's Range	N/A - N/A
Shares Out	46.84M
Stochastic %K	59%
Beta	0.81
Analysts	Strong Sell
Price Target	$3.67